SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.09.19 | Novartis Underweight | Barclays Capital | |
| 02.09.19 | Roche buy | Deutsche Bank AG | |
| 30.08.19 | Novartis Hold | Deutsche Bank AG | |
| 30.08.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.08.19 | Novartis buy | Jefferies & Company Inc. | |
| 29.08.19 | Roche buy | Jefferies & Company Inc. | |
| 29.08.19 | Novartis buy | Jefferies & Company Inc. | |
| 28.08.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.08.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.08.19 | BB Biotech neutral | Independent Research GmbH | |
| 23.08.19 | Alcon buy | Goldman Sachs Group Inc. | |
| 22.08.19 | Alcon Neutral | JP Morgan Chase & Co. | |
| 22.08.19 | Roche Reduce | HSBC | |
| 06.08.19 | Roche buy | Deutsche Bank AG | |
| 05.08.19 | Roche overweight | Barclays Capital | |
| 30.07.19 | Roche buy | Goldman Sachs Group Inc. | |
| 29.07.19 | Novartis Neutral | UBS AG | |
| 29.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.07.19 | Roche buy | Deutsche Bank AG | |
| 26.07.19 | Roche Neutral | Credit Suisse Group | |
| 26.07.19 | Roche buy | UBS AG | |
| 25.07.19 | Roche buy | Jefferies & Company Inc. | |
| 25.07.19 | Roche Neutral | UBS AG | |
| 24.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.07.19 | Novartis Neutral | UBS AG | |
| 22.07.19 | Roche buy | Deutsche Bank AG | |
| 22.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.07.19 | Novartis Hold | HSBC | |
| 19.07.19 | Roche buy | Goldman Sachs Group Inc. | |
| 19.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.19 | Novartis Neutral | Credit Suisse Group | |
| 19.07.19 | Novartis Hold | Deutsche Bank AG | |
| 19.07.19 | Novartis Underweight | Barclays Capital | |
| 18.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.07.19 | Novartis Neutral | UBS AG | |
| 18.07.19 | Novartis Neutral | UBS AG | |
| 18.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.07.19 | Novartis Underweight | JP Morgan Chase & Co. |